EUR/GBP dips while GBP/USD resumes its ascent and AUD/USD grapples with resistance
EUR/GBP dips while GBP/USD resumes its ascent and AUD/USD grapples with resistance amid ongoing US tariff talks with several countries.
EUR/GBP dips
EUR/GBP's drop through the 10 April £0.8520 low has so far taken it to £0.8487, close to the January high at £0.8473 which may act as minor support.
Because of inverse polarity the recent daily lows at £0.8520-to-£0.8531 may now act as resistance ahead of the more important £0.8613-to-£0.8623 resistance zone.
Only if overcome, would the December 2023 peak at £0.8714 and the current April peak at £0.8738 high be back in sight.
EUR/GBP daily chart
GBP/USD resumes its ascent
GBP/USD has resumed its ascent and in doing so has risen above last week's high at $1.3424 with the February 2022 low at $1.3487 representing the next upside target.
Minor support sits at Monday's $1.3280 low ahead of Wednesday's $1.3234 low.
GBP/USD daily chart
AUD/USD grapples with resistance
AUD/USD is still trying to break through its February-to- April highs at $0.6388-to-$0.6439, having recovered from Thursday's $0.6344 low.
The 200-day simple moving average (SMA) at $0.6459 represents the next upside target but may short-term cap.
Below $0.6344 slithers the 55-day SMA at $0.6300.
AUD/USD daily chart
Connect with us
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Professional clients trading spread bets and CFDs can lose more than they deposit.
Options and futures are complex instruments which come with a high risk of losing money rapidly due to leverage. They’re not suitable for most investors. Before you invest, you should consider whether you understand how options and futures work, the risks of trading these instruments and whether you can afford to lose more than your original investment.
Trading stocks and shares ‘on margin’ within a US options and futures account – meaning that you only finance part of the cost of acquiring a position in a security – carries additional risks over buying securities on a fully funded basis and may result in losses exceeding your original investment. Trading on margin will also result in additional costs to you as the investor and any securities purchased using margin may be held as collateral by the lender, restricting both your rights as shareholder, and your ability to use the securities until the margin trade is closed. You should familiarise yourself with these risks before trading on margin.
The value of shares, ETFs and other ETPs bought through a share dealing account, a US options and futures account, a stocks and shares ISA or a SIPP can fall as well as rise, which could mean getting back less than you originally put in. Past performance is no guarantee of future results. Some ETPs carry additional risks depending on how they’re structured, investors should ensure they familiarise themselves with the differences before investing.
Share dealing and IG Smart Portfolio accounts provided by IG Trading and Investments Ltd, CFD accounts and US options and futures accounts are provided by IG Markets Ltd, spread betting provided by IG Index Ltd.
IG is a trading name of IG Trading and Investments Ltd (a company registered in England and Wales under number 11628764), IG Markets Ltd (a company registered in England and Wales under number 04008957) and IG Index Ltd (a company registered in England and Wales under number 01190902). Registered address at Cannon Bridge House, 25 Dowgate Hill, London EC4R 2YA. IG Markets Ltd (Register number 195355), IG Trading and Investments Ltd (Register Number 944492) and IG Index Ltd (Register number 114059) are authorised and regulated by the Financial Conduct Authority.
The information on this site isn’t directed at residents of the United States, Belgium or any particular country outside the UK and isn’t intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.